The Therapeutic Potential of Common Herbal and Nano-Based Herbal Formulations against Ovarian Cancer: New Insight into the Current Evidence.
curcumin
herbal medicine
nanotechnology
quercetin
resveratrol
Journal
Pharmaceuticals (Basel, Switzerland)
ISSN: 1424-8247
Titre abrégé: Pharmaceuticals (Basel)
Pays: Switzerland
ID NLM: 101238453
Informations de publication
Date de publication:
17 Dec 2021
17 Dec 2021
Historique:
received:
04
11
2021
revised:
28
11
2021
accepted:
30
11
2021
entrez:
28
12
2021
pubmed:
29
12
2021
medline:
29
12
2021
Statut:
epublish
Résumé
Ovarian cancer (OCa) is characterized as one of the common reasons for cancer-associated death in women globally. This gynecological disorder is chiefly named the "silent killer" due to lacking an association between disease manifestations in the early stages and OCa. Because of the disease recurrence and resistance to common therapies, discovering an effective therapeutic way against the disease is a challenge. According to documents, some popular herbal formulations, such as curcumin, quercetin, and resveratrol, can serve as an anti-cancer agent through different mechanisms. However, these herbal products may be accompanied by some pharmacological limitations, such as poor bioavailability, instability, and weak water solubility. On the contrary, using nano-based material, e.g., nanoparticles (NPs), micelles, liposomes, can significantly solve these limitations. Therefore, in the present study, we will summarize the anti-cancer aspects of these herbal and-nano-based herbal formulations with a focus on their mechanisms against OCa.
Identifiants
pubmed: 34959716
pii: ph14121315
doi: 10.3390/ph14121315
pmc: PMC8705681
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Gynecol Oncol. 2007 Dec;107(3):450-7
pubmed: 17825886
BMC Cancer. 2011 Jan 27;11:39
pubmed: 21272366
J Ovarian Res. 2019 Mar 26;12(1):26
pubmed: 30914056
J Control Release. 2016 Nov 10;241:110-124
pubmed: 27663228
Cancer Med. 2016 Aug;5(8):2061-8
pubmed: 27227569
Phytother Res. 2018 Nov;32(11):2109-2130
pubmed: 30039547
Mater Sci Eng C Mater Biol Appl. 2019 Jul;100:129-140
pubmed: 30948047
Nanoscale. 2011 Apr;3(4):1558-67
pubmed: 21283869
Front Oncol. 2021 Apr 12;11:660712
pubmed: 33912467
Reprod Sci. 2014 Apr;21(4):503-8
pubmed: 24077440
Arch Gynecol Obstet. 2019 Jun;299(6):1627-1639
pubmed: 31006841
Cancer Res. 2004 Jan 15;64(2):696-703
pubmed: 14744787
J Nutr Biochem. 2018 Jan;51:105-113
pubmed: 29125991
J Immunol Res. 2021 May 14;2021:6636791
pubmed: 34095320
Oncol Lett. 2016 Nov;12(5):3944-3948
pubmed: 27895754
J Ovarian Res. 2020 Mar 19;13(1):30
pubmed: 32192517
Cytokine. 2012 May;58(2):133-47
pubmed: 22349527
Nanoscale. 2016 Mar 7;8(9):5126-38
pubmed: 26875690
Pathol Res Pract. 2019 Oct;215(10):152556
pubmed: 31358480
Oncol Rep. 2020 Jun;43(6):1755-1770
pubmed: 32186777
Chirality. 2010 Jun;22(6):593-6
pubmed: 19902529
J Proteomics. 2021 Jan 6;230:103964
pubmed: 32898699
Oncogene. 2007 May 17;26(23):3364-77
pubmed: 17160022
Nanoscale Res Lett. 2014 Jul 09;9(1):343
pubmed: 25114637
Eur J Pharmacol. 2008 May 13;585(2-3):325-37
pubmed: 18417116
J Cell Physiol. 2019 Jul;234(7):11023-11036
pubmed: 30633343
J Womens Health (Larchmt). 2020 Jan;29(1):111-118
pubmed: 31314677
Free Radic Biol Med. 2018 Sep;125:15-24
pubmed: 29601945
Biomed Res Int. 2014;2014:249393
pubmed: 25295252
Adv Pharm Bull. 2014 Oct;4(Suppl 1):421-7
pubmed: 25364657
J Oncol. 2010;2010:932371
pubmed: 19746182
J Biomed Nanotechnol. 2013 Jun;9(6):965-75
pubmed: 23858960
Semin Oncol Nurs. 2019 Apr;35(2):151-156
pubmed: 30867104
Front Pharmacol. 2015 Nov 05;6:262
pubmed: 26594174
J Agric Food Chem. 2017 Feb 22;65(7):1342-1352
pubmed: 28111949
RSC Adv. 2018 Jun 11;8(38):21229-21242
pubmed: 35539921
Mol Cancer. 2006 Oct 17;5:45
pubmed: 17044934
ACS Omega. 2020 May 14;5(20):11849-11872
pubmed: 32478277
Int J Nanomedicine. 2020 Dec 03;15:9703-9715
pubmed: 33299312
Int J Nanomedicine. 2019 Dec 02;14:9453-9467
pubmed: 31819443
Science. 1997 Apr 4;276(5309):111-3
pubmed: 9082980
Life Sci. 2018 Aug 15;207:340-349
pubmed: 29959028
J Clin Immunol. 2003 Sep;23(5):317-32
pubmed: 14601641
Oncogenesis. 2021 Jul 12;10(7):48
pubmed: 34253709
Colloids Surf B Biointerfaces. 2020 Apr;188:110762
pubmed: 31911391
J Mater Chem. 2010 Jan 1;20(3):547-554
pubmed: 20436942
PLoS One. 2014 Jan 22;9(1):e86987
pubmed: 24466305
Anticancer Agents Med Chem. 2021;21(6):775-781
pubmed: 32767955
Clin Cancer Res. 1999 Sep;5(9):2485-90
pubmed: 10499623
Exp Ther Med. 2015 Aug;10(2):579-583
pubmed: 26622357
J Transl Med. 2004 Jun 25;2(1):23
pubmed: 15219235
Mol Biosyst. 2012 Apr;8(4):1078-87
pubmed: 22234583
Cell Biol Int. 2006 Mar;30(3):221-6
pubmed: 16376585
Int J Mol Sci. 2019 Jun 28;20(13):
pubmed: 31261749
Int J Cancer. 2000 Jan 15;85(2):160-5
pubmed: 10629071
Oxid Med Cell Longev. 2020 Apr 28;2020:2415324
pubmed: 32411322
Phytother Res. 2014 Oct;28(10):1553-60
pubmed: 24831732
Semin Cancer Biol. 2016 Oct;40-41:209-232
pubmed: 26774195
Cancer Prev Res (Phila). 2018 Jan;11(1):59-67
pubmed: 29089332
Cancer Cell. 2006 Jun;9(6):419-20
pubmed: 16766260
Apoptosis. 2017 Apr;22(4):544-557
pubmed: 28188387
Nutrients. 2017 Nov 10;9(11):
pubmed: 29125563
Curr Drug Targets. 2011 Jul 1;12(8):1131-50
pubmed: 21443476
Chem Biol Interact. 2019 Feb 25;300:91-100
pubmed: 30639267
Cancer Lett. 2010 Jun 28;292(2):228-36
pubmed: 20083342
Eur J Pharm Sci. 2018 Jun 5;121:356-381
pubmed: 29883727
Cancer Cell Int. 2019 Jul 15;19:180
pubmed: 31341423
Biomed Pharmacother. 2017 Aug;92:33-38
pubmed: 28528183
Cancer Lett. 2001 Jun 26;167(2):151-6
pubmed: 11369135
Tumori. 1987 Feb 28;73(1):29-31
pubmed: 2435036
Evid Based Complement Alternat Med. 2011;2011:591356
pubmed: 21792362
Curr Probl Cancer. 2007 Jul-Aug;31(4):243-305
pubmed: 17645940
Cancer. 2016 Mar 1;122(5):722-9
pubmed: 26619367
Int J Pharm. 2018 Oct 5;549(1-2):230-238
pubmed: 30071310
Recent Pat Nanotechnol. 2022;16(4):283-294
pubmed: 34303336
Front Pharmacol. 2021 Jan 18;11:603235
pubmed: 33536913
Int J Oncol. 2008 May;32(5):1119-23
pubmed: 18425340
Clin Cancer Res. 2015 Jan 1;21(1):211-20
pubmed: 25348513
Hum Exp Toxicol. 2009 Aug;28(8):493-503
pubmed: 19755441
J Biol Chem. 2004 Dec 31;279(53):55875-85
pubmed: 15456784
Gynecol Oncol. 2017 Jun;145(3):595-602
pubmed: 28237618
Sci Rep. 2021 Mar 8;11(1):5438
pubmed: 33686173
Cell Biosci. 2020 Mar 10;10:32
pubmed: 32175075
Onco Targets Ther. 2017 Dec 21;11:17-27
pubmed: 29317830
BMC Cancer. 2018 Dec 10;18(1):1230
pubmed: 30526546
Curr Res Pharmacol Drug Discov. 2021 Jul 08;2:100034
pubmed: 34909665
Oncol Rep. 2008 Dec;20(6):1553-9
pubmed: 19020741
Nat Rev Cancer. 2011 Mar;11(3):211-8
pubmed: 21326325
Cancer Biother Radiopharm. 2010 Aug;25(4):471-7
pubmed: 20735207
Nutrients. 2016 Aug 29;8(9):
pubmed: 27589790
Phytother Res. 2020 Nov 17;:
pubmed: 33205472
Cancer Biol Med. 2017 Feb;14(1):9-32
pubmed: 28443200
Mol Cancer Res. 2013 Dec;11(12):1521-9
pubmed: 24072817
J Ovarian Res. 2019 Jun 15;12(1):55
pubmed: 31202269
Cancer Rep (Hoboken). 2021 Jun;4(3):e1353
pubmed: 33655717
Cancer Sci. 2014 May;105(5):520-7
pubmed: 24612139
J Mater Sci Mater Med. 2013 Sep;24(9):2137-44
pubmed: 23779153
Adv Exp Med Biol. 2021;1291:363-373
pubmed: 34331701
J Nutr Biochem. 2005 Aug;16(8):449-66
pubmed: 16043028
J Ovarian Res. 2015 Apr 22;8:25
pubmed: 25896424
World J Surg Oncol. 2018 Jun 14;16(1):108
pubmed: 29898731
Anticancer Agents Med Chem. 2009 Feb;9(2):138-61
pubmed: 19199862
Drug Des Devel Ther. 2020 Dec 30;14:5747-5756
pubmed: 33408463
J Cell Biochem. 2018 Jul;119(7):6162-6172
pubmed: 29663499
Nanoscale. 2012 Nov 21;4(22):7021-30
pubmed: 23044718
Biofactors. 2020 May;46(3):356-366
pubmed: 31880372
Life Sci. 2021 Feb 1;266:118914
pubmed: 33340527
J Control Release. 2014 Jan 28;174:27-36
pubmed: 24231407
J Agric Food Chem. 2010 Mar 10;58(5):2848-53
pubmed: 20146520
Phytomedicine. 2019 Jan;52:117-128
pubmed: 30599890